Seeking Alpha

Schering-Plough Corp. (SGP)

()

News & PR
Market Currents

Buzz
Twitter: SGP

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Paulson & Co's Latest Portfolio: 13F Filing

Dec 4 • Market Folly • 4 Comments
Dan Loeb: Investment Outlook 'Favorable' Through Mid-2010

Dec 2 • Market Folly • 3 Comments
What Are the Best Hedge Funds Buying Now?

Nov 19 • The Pragmatic Capitalist • 7 Comments
Will the M&A Wave Push Financial ETFs Higher?

Nov 16 • Eric Dutram • Comment!
The Real Price of Big Pharma's Huge Fines

Nov 10 • Derek Lowe • 6 Comments
Johnson & Johnson: The Elephant in the Merck-Schering Living Room

Nov 4 • EP Vantage • 1 Comment
Latest Merger Arbitrage Spreads

Nov 2 • The Pragmatic Capitalist • Comment!
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Wall Street Breakfast: Must-Know News

Oct 23 • SA Editor Eli Hoffmann • 19 Comments
Wall Street Breakfast: Must-Know News

Oct 22 • SA Editor Eli Hoffmann • 11 Comments
Ramius Capital Buys Drug Companies, Moves Out of ETFs

Sep 15 • Todd Walker • Comment!
Top Performing S&P 500 Stocks Since the Lehman Bankruptcy

Sep 14 • Bespoke Investment Group • 2 Comments
Closing Update: Stocks Manage Narrowly Higher Finish

Sep 14 • Midnight Trader • 3 Comments
Small Cap Stocks Battling Brain Cancer

Sep 7 • Mike Havrilla • 4 Comments
Hedge Fund Blue Ridge Concentrates on Apple

Sep 3 • Market Folly • 4 Comments
Potential Profit from Fall Allergy Season

Sep 2 • Douglas Cress • Comment!
Eton Park Loads Up on Options

Sep 2 • Market Folly • 3 Comments
Dainippon Sumitomo Picks a Hard Fight for Its First U.S. Foray

Aug 27 • EP Vantage • Comment!
Is It Worth Investing in the Merck / Schering Merger Now?

Aug 23 • BioPharma Investor • 7 Comments
Moore Capital Is Buying: China, Financials and Consumer Staples

Aug 20 • Todd Walker • Comment!
The Few, The Proud, The Stocks Above Pre-Lehman Levels

Aug 17 • Bespoke Investment Group • 1 Comment
Ariad Pharmaceuticals: Significant Catalysts Approaching

Aug 14 • Justin M. Hall • 27 Comments
Atticus Capital to Close $3 Billion Fund

Aug 11 • Bespoke Investment Group • 1 Comment
Manikay Partners Buy Healthcare, Dump Financials

Aug 10 • Todd Walker • 1 Comment
Time to Get Conservative? 50 Ideas for a Summer Sell-Off

Aug 3 • Marco Hickey • 16 Comments
July Was a Good Month for Biotech

Aug 2 • The Burrill Report • 1 Comment
FDA Calendar Updates: Anadys, Merck, Schering-Plough

Jul 31 • Mike Havrilla • Comment!
Wall Street Breakfast: Must-Know News

Jul 30 • SA Editor Rachael Granby • 16 Comments
FDA Calendar Updates: Schering-Plough, Shire, Elron Electronics, Cardium

Jul 28 • Mike Havrilla • Comment!
Sepracor Guides Up

Jul 27 • Zacks.com • Comment!
FDA Calendar Updates: Schering-Plough, Hemispherx, Bovie Medical

Jul 23 • Mike Havrilla • Comment!
Wall Street Breakfast: Must-Know News

Jul 21 • SA Editor Rachael Granby • 10 Comments
Preview from Europe: Onward and Upward for Equities

Jul 21 • The Mole • 1 Comment
Schering's HIV Drug Moves Further Along the Pipeline

Jul 17 • Zacks.com • 2 Comments
Portfolio Update: Raising Tech, St. Jude Stakes

Jul 16 • Ryan Barnes • 2 Comments
Alternate Short Strategy: Put Protection for Less (Part III)

Jul 12 • Marco Hickey • 1 Comment
Dan Loeb's Third Point Hedge Fund Favoring 'Blank Check' Companies

Jul 10 • Market Folly • 1 Comment
Clarium Makes Huge Play on Oil Services

Jul 2 • Market Folly • 2 Comments
Generic Players Continue to Impress in H1

Jul 2 • EP Vantage • Comment!
Why I'm Shifting Portfolio Sector Weightings

Jul 1 • Ryan Barnes • 1 Comment
Smaller Pharma Wins the 'Most Valuable' Race

Jul 1 • EP Vantage • 1 Comment

Schering-Plough Corp. (SGP)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers